Cargando…

Battle at the entrance gate: CIITA as a weapon to prevent the internalization of SARS-CoV-2 and Ebola viruses

Detalles Bibliográficos
Autores principales:	Butowt, Rafal, Pyrc, Krzysztof, von Bartheld, Christopher S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683872/ https://www.ncbi.nlm.nih.gov/pubmed/33235189 http://dx.doi.org/10.1038/s41392-020-00405-2

Ejemplares similares

Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle
por: Popowicz, Grzegorz Maria, et al.
Publicado: (2022)

The route of SARS-CoV-2 to brain infection: have we been barking up the wrong tree?
por: Butowt, Rafal, et al.
Publicado: (2022)

Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor
por: Butowt, Rafal, et al.
Publicado: (2020)

Expression of the ACE2 virus entry protein in the nervus terminalis reveals the potential for an alternative route to brain infection in COVID-19
por: Bilinska, Katarzyna, et al.
Publicado: (2021)

New study on prevalence of anosmia in COVID-19 implicates the D614G virus mutation as a major contributing factor to chemosensory dysfunction
por: von Bartheld, Christopher S., et al.
Publicado: (2021)

Expression of the ACE2 Virus Entry Protein in the Nervus Terminalis Reveals the Potential for an Alternative Route to Brain Infection in COVID-19
por: Bilinska, Katarzyna, et al.
Publicado: (2021)

Why Does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in Coronavirus Disease 2019( )
por: Butowt, Rafal, et al.
Publicado: (2022)

Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms
por: Butowt, Rafal, et al.
Publicado: (2023)

Secret Weapon in the Battle Against Cavities?
por: Damle, S. G.
Publicado: (2017)

Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences
por: von Bartheld, Christopher S., et al.
Publicado: (2020)

The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models
por: Butowt, Rafal, et al.
Publicado: (2021)

MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses
por: Bruchez, Anna, et al.
Publicado: (2020)

Blocking the Entrance to Open the Gate
por: Schrauwen, Patrick, et al.
Publicado: (2013)

Another Weapon in the Battle against Idiopathic Pulmonary Fibrosis?
por: Wilson, Carole L., et al.
Publicado: (2019)

A gating mechanism of K2P channels by their selectivity filter
por: Yang, Fan
Publicado: (2022)

A promiscuous interaction of SARS-CoV-2 with bacterial products
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Virtual Issue on SARS-CoV-2: Evolution of a Pandemic
por: McGrath, Casey
Publicado: (2023)

Cancer-host battles: measures and countermeasures in radiation-induced caspase activation and tumor immunogenicity
por: Rosado, M. M., et al.
Publicado: (2020)

LNKs-RVEs complex ticks in the circadian gating of plant temperature stress responses
por: Xu, Xiaodong, et al.
Publicado: (2023)

Autoimmunity and SARS‐CoV‐2 infection: Unraveling the link in neurological disorders
por: Latorre, Daniela
Publicado: (2022)

Bacterial conversion of a host weapon into a nutritional signal
por: Valvano, Miguel A.
Publicado: (2022)

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation
por: Yao, Tong, et al.
Publicado: (2022)

COVID-19 therapy: What weapons do we bring into battle?
por: de Almeida, Sinara Mônica Vitalino, et al.
Publicado: (2020)

Drug repurposing for breast cancer therapy: Old weapon for new battle
por: Aggarwal, Sadhna, et al.
Publicado: (2021)

Battling COVID-19: using old weapons for a new enemy
por: Kumar, Rohit, et al.
Publicado: (2020)

Kidney injury molecule-1: a novel entry factor for SARS-CoV-2
por: Wan, Cheng, et al.
Publicado: (2021)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

A two‐step infection model: From SARS‐CoV‐2 entry and trafficking to egress and spread
por: You, Liting, et al.
Publicado: (2023)

Fast vaccine offers hope in battle with Ebola
por: Clarke, Tom
Publicado: (2003)

Fast vaccine offers hope in battle with Ebola
por: Clarke, Tom, et al.
Publicado: (2003)

New automated gate at entrance A of the Meyrin site
por: Bennett, Sophia Elizabeth
Publicado: (2016)

Antigen‐dependent multistep differentiation of T follicular helper cells and its role in SARS‐CoV‐2 infection and vaccination
por: Baumjohann, Dirk, et al.
Publicado: (2021)

Type I interferon signaling deficiency results in dysregulated innate immune responses to SARS‐CoV‐2 in mice
por: Ogger, Patricia P., et al.
Publicado: (2022)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

Level up for culture models - How 3D cell culture models benefit SARS-CoV-2 research
por: Häfner, Sophia Julia
Publicado: (2021)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Little evidence for community treatment orders – a battle fought with heavy weapons
por: Heun, Reinhard, et al.
Publicado: (2016)

SARS attacks!()
por: Häfner, Sophia
Publicado: (2013)

Living Weapons: Biological Weapons and International Security
por: Cieslak, Theodore J.
Publicado: (2010)

Cohesin’s DNA Exit Gate Is Distinct from Its Entrance Gate and Is Regulated by Acetylation
por: Chan, Kok-Lung, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gqo321c0u209m0vn5k39gl5je0